Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.
暂无分享,去创建一个
Y Agid | E. Hirsch | Y. Agid | M. Ruberg | D. Ricard | M. Muriel | S. Hunot | P. Michel | B. Faucheux | E. Hirsch | M Ruberg | B. Brugg | B A Faucheux | E C Hirsch | S Hunot | B Brugg | D Ricard | P P Michel | M P Muriel | D. Ricard
[1] Y. Hannun,et al. Ceramide: an intracellular signal for apoptosis. , 1995, Trends in biochemical sciences.
[2] G. Bing,et al. Induction of NF‐kB‐like transcription factors in brain areas susceptible to kainate toxicity , 1996, Glia.
[3] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[4] Y. Agid,et al. Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.
[5] A. Haimovitz-Friedman,et al. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[6] S. Grimm,et al. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis , 1996, The Journal of cell biology.
[7] Simon C Watkins,et al. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. , 1994, The Journal of biological chemistry.
[8] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[9] Y. Christen,et al. Free Radicals in the Brain , 1992, Springer Berlin Heidelberg.
[10] Y. Agid,et al. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[11] R. Kolesnick,et al. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling , 1994, Cell.
[12] Y. Mizuno,et al. Histochemical detection of apoptosis in Parkinson's disease , 1996, Journal of the Neurological Sciences.
[13] E. Hirsch,et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.
[14] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[15] F. Cope,et al. Apoptosis II: The Molecular Basis of Apoptosis in Disease , 1994 .
[16] Y. Agid,et al. Chronic Activation of the Cyclic AMP Signaling Pathway Promotes Development and Long‐Term Survival of Mesencephalic Dopaminergic Neurons , 1996, Journal of neurochemistry.
[17] C. Marsden,et al. A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.
[18] Y. Agid,et al. Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.
[19] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[20] Y. Agid,et al. Distribution of manganese-dependent superoxide dismutase in the human brain , 1994, Neuroscience.
[21] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[22] Y. Agid,et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.
[23] P. Mcgeer,et al. Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease , 1996, Brain Research.
[24] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[25] T. Maniatis,et al. NF-κB: A lesson in family values , 1995, Cell.
[26] M. Memo,et al. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.
[27] W. Fiers,et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.
[28] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[29] C. Marsden,et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.
[30] W. Fiers,et al. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.
[31] Y. Agid,et al. Ceramide Induces Apoptosis in Cultured Mesencephalic Neurons , 1996, Journal of neurochemistry.
[32] D. Baltimore,et al. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. , 1989, Genes & development.
[33] A. Frankfurter,et al. Heterogeneity of microtubule-associated protein 2 during rat brain development. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.